17.13

4.52% -0.81

Pre-market: 16.82 -0.31 -1.81%

Fulgent Genetics Inc (FLGT)

Overview News Price History Option Chain Financials Discussions Forecast

Fulgent Genetics Inc stock is traded at $17.13, with a volume of 327.80K. It is down -4.52% in the last 24 hours and down -12.51% over the past month. Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

Previous Close:

$17.94

Open:

$18.04

24h Volume:

327.80K

Relative Volume:

1.43

Market Cap:

$523.95M

Revenue:

$290.71M

Net Income/Loss:

$-163.43M

P/E Ratio:

-3.1259

EPS:

-5.48

Net Cash Flow:

$11.70M

1W Performance:

-9.60%

1M Performance:

-12.51%

6M Performance:

-18.23%

1Y Performance:

-38.76%

1-Day Range:

$16.88

$18.04

1-Week Range:

$16.88

$18.95

52-Week Range:

$16.56

$27.56

Fulgent Genetics Inc Stock (FLGT) Company Profile

Name

Fulgent Genetics Inc

Sector

Healthcare (1191)

Industry

Diagnostics & Research (58)

Phone

626-350-0537

Address

4399 SANTA ANITA AVE, EL MONTE

Employee

1,012

Twitter

@FulgentGenetics

Next Earnings Date

2024-11-08

Latest SEC Filings

FLGT's Discussions on Twitter

Compare FLGT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
FLGT Fulgent Genetics Inc	17.13	523.95M	290.71M	-163.43M	11.70M	-5.48
TMO Thermo Fisher Scientific Inc	556.99	213.05B	42.37B	6.14B	7.78B	15.95
DHR Danaher Corp	237.62	171.63B	23.74B	3.89B	4.98B	5.24
A Agilent Technologies Inc	143.43	40.54B	6.51B	1.29B	1.37B	4.42
IQV Iqvia Holdings Inc	197.96	35.93B	15.32B	1.41B	1.96B	7.62
IDXX Idexx Laboratories Inc	418.63	34.28B	3.84B	866.24M	792.60M	10.37

Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-07-23	Initiated	UBS	Neutral
Dec-08-22	Downgrade	Piper Sandler	Overweight → Neutral
Nov-18-22	Initiated	Raymond James	Outperform
Aug-25-22	Initiated	Credit Suisse	Outperform
Feb-04-22	Resumed	Piper Sandler	Overweight
Aug-05-21	Resumed	Credit Suisse	Underperform
Jan-08-21	Downgrade	Credit Suisse	Neutral → Underperform
Nov-24-20	Downgrade	BTIG Research	Buy → Neutral
Aug-20-20	Initiated	Oppenheimer	Outperform
May-29-20	Initiated	BTIG Research	Buy
Nov-05-19	Upgrade	Piper Jaffray	Neutral → Overweight
Mar-01-18	Downgrade	Piper Jaffray	Overweight → Neutral
Nov-07-17	Downgrade	Raymond James	Outperform → Mkt Perform

View All

Fulgent Genetics Inc Stock (FLGT) Latest News

05:07 AM

Does Fulgent Genetics (NASDAQ:FLGT) Have A Healthy Balance Sheet? - Simply Wall St

05:07 AM

03:40 AM

JPMorgan Chase & Co. Raises Stock Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

03:40 AM

03:06 AM

When the Price of (FLGT) Talks, People Listen - Stock Traders Daily

03:06 AM

Jan 08, 2025

Millennium Management LLC Expands Stake in Fulgent Genetics Inc. - GuruFocus.com

Jan 08, 2025

Jan 04, 2025

Principal Financial Group Inc. Cuts Position in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Jan 04, 2025

Jan 03, 2025

Franklin Resources Inc. Invests $215,000 in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Jan 03, 2025

Jan 01, 2025

Geode Capital Management LLC Grows Stock Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Jan 01, 2025

FULGENT GENETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Fulgent - AccessWire

Jan 01, 2025

Dec 31, 2024

FULGENT GENETICS, INC. (NASDAQ:FLGT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fulgent Genetics, Inc. (NASDAQ:FL - AccessWire

Dec 31, 2024

Fulgent Genetics, Inc. (NASDAQ:FLGT) Short Interest Update - MarketBeat

Dec 31, 2024

Dec 25, 2024

State Street Corp Has $17.24 Million Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Dec 25, 2024

Fmr LLC Cuts Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Dec 25, 2024

Dec 24, 2024

Fulgent Genetics: High Insider Ownership Supports Asymmetric Upside (NASDAQ:FLGT) - Seeking Alpha

Dec 24, 2024

Dec 23, 2024

Barclays PLC Has $3.80 Million Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat

Dec 23, 2024

Dec 21, 2024

With 54% ownership, Fulgent Genetics, Inc. (NASDAQ:FLGT) boasts of strong institutional backing - Yahoo Finance

Dec 21, 2024

Dec 19, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Holdings in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World

Dec 19, 2024

Dec 18, 2024

Fulgent Genetics: A Value Stock With Caveats (Rating Downgrade) (NASDAQ:FLGT) - Seeking Alpha

Dec 18, 2024

Dec 15, 2024

Short Interest in Fulgent Genetics, Inc. (NASDAQ:FLGT) Increases By 29.3% - MarketBeat

Dec 15, 2024